335 related articles for article (PubMed ID: 32275832)
1. What We Need to Know about Solid-State Isothermal Crystallization of Organic Molecules from the Amorphous State below the Glass Transition Temperature.
Newman A; Zografi G
Mol Pharm; 2020 Jun; 17(6):1761-1777. PubMed ID: 32275832
[TBL] [Abstract][Full Text] [Related]
2. What Are the Important Factors That Influence API Crystallization in Miscible Amorphous API-Excipient Mixtures during Long-Term Storage in the Glassy State?
Newman A; Zografi G
Mol Pharm; 2022 Feb; 19(2):378-391. PubMed ID: 34378939
[TBL] [Abstract][Full Text] [Related]
3. Relaxation Dynamics vs Crystallization Kinetics in the Amorphous State: The Case of Stiripentol.
Ruiz GN; Romanini M; Barrio M; Tamarit JL; Pardo LC; Macovez R
Mol Pharm; 2017 Nov; 14(11):3636-3643. PubMed ID: 28915351
[TBL] [Abstract][Full Text] [Related]
4. Relaxation dynamics and crystallization study of sildenafil in the liquid and glassy states.
Kolodziejczyk K; Paluch M; Grzybowska K; Grzybowski A; Wojnarowska Z; Hawelek L; Ziolo JD
Mol Pharm; 2013 Jun; 10(6):2270-82. PubMed ID: 23594226
[TBL] [Abstract][Full Text] [Related]
5. Crystallization kinetics and molecular mobility of an amorphous active pharmaceutical ingredient: A case study with Biclotymol.
Schammé B; Couvrat N; Malpeli P; Delbreilh L; Dupray V; Dargent É; Coquerel G
Int J Pharm; 2015 Jul; 490(1-2):248-57. PubMed ID: 26003417
[TBL] [Abstract][Full Text] [Related]
6. Comparative Physical Study of Three Pharmaceutically Active Benzodiazepine Derivatives: Crystalline versus Amorphous State and Crystallization Tendency.
Valenti S; Barrio M; Negrier P; Romanini M; Macovez R; Tamarit JL
Mol Pharm; 2021 Apr; 18(4):1819-1832. PubMed ID: 33689364
[TBL] [Abstract][Full Text] [Related]
7. Influence of molecular mobility on the physical stability of amorphous pharmaceuticals in the supercooled and glassy States.
Kothari K; Ragoonanan V; Suryanarayanan R
Mol Pharm; 2014 Sep; 11(9):3048-55. PubMed ID: 25105216
[TBL] [Abstract][Full Text] [Related]
8. Molecular relaxation behavior and isothermal crystallization above glass transition temperature of amorphous hesperetin.
Shete G; Khomane KS; Bansal AK
J Pharm Sci; 2014 Jan; 103(1):167-78. PubMed ID: 24186540
[TBL] [Abstract][Full Text] [Related]
9. Correlation between Molecular Mobility and Physical Stability in Pharmaceutical Glasses.
Mehta M; Ragoonanan V; McKenna GB; Suryanarayanan R
Mol Pharm; 2016 Apr; 13(4):1267-77. PubMed ID: 26895136
[TBL] [Abstract][Full Text] [Related]
10. Crystallization of indomethacin from the amorphous state below and above its glass transition temperature.
Yoshioka M; Hancock BC; Zografi G
J Pharm Sci; 1994 Dec; 83(12):1700-5. PubMed ID: 7891297
[TBL] [Abstract][Full Text] [Related]
11. Origin of two modes of non-isothermal crystallization of glasses produced by milling.
Chattoraj S; Bhugra C; Telang C; Zhong L; Wang Z; Sun CC
Pharm Res; 2012 Apr; 29(4):1020-32. PubMed ID: 22173781
[TBL] [Abstract][Full Text] [Related]
12. Dielectric study of the molecular mobility and the isothermal crystallization kinetics of an amorphous pharmaceutical drug substance.
Alie J; Menegotto J; Cardon P; Duplaa H; Caron A; Lacabanne C; Bauer M
J Pharm Sci; 2004 Jan; 93(1):218-33. PubMed ID: 14648651
[TBL] [Abstract][Full Text] [Related]
13. Predicting Crystallization of Amorphous Drugs with Terahertz Spectroscopy.
Sibik J; Löbmann K; Rades T; Zeitler JA
Mol Pharm; 2015 Aug; 12(8):3062-8. PubMed ID: 26090554
[TBL] [Abstract][Full Text] [Related]
14. Isothermal Crystallization Monitoring and Time-Temperature-Transformation of Amorphous GDC-0276: Differential Scanning Calorimetric and Rheological Measurements.
Cheng S; Chakravarty P; Nagapudi K; McKenna GB
Mol Pharm; 2021 Jan; 18(1):158-173. PubMed ID: 33259220
[TBL] [Abstract][Full Text] [Related]
15. Molecular mobility of amorphous S-flurbiprofen: a dielectric relaxation spectroscopy approach.
Rodrigues AC; Viciosa MT; Danède F; Affouard F; Correia NT
Mol Pharm; 2014 Jan; 11(1):112-30. PubMed ID: 24215236
[TBL] [Abstract][Full Text] [Related]
16. Glass transition, crystallization kinetics, and inter-conformer relaxation dynamics of amorphous mitotane and related compounds.
Romanini M; Pérez Valmaseda A; Macovez R
Int J Pharm; 2022 Dec; 629():122390. PubMed ID: 36379398
[TBL] [Abstract][Full Text] [Related]
17. Influence of Annealing in the Close Vicinity of
Kamińska E; Minecka A; Tarnacka M; Hachuła B; Kamiński K; Paluch M
Mol Pharm; 2020 Mar; 17(3):990-1000. PubMed ID: 31961694
[TBL] [Abstract][Full Text] [Related]
18. Interrelationships Between Structure and the Properties of Amorphous Solids of Pharmaceutical Interest.
Zografi G; Newman A
J Pharm Sci; 2017 Jan; 106(1):5-27. PubMed ID: 27372552
[TBL] [Abstract][Full Text] [Related]
19. Influence of Nucleation on Relaxation, Molecular Cooperativity, and Physical Stability of Celecoxib Glass.
Han X; Dai K; Kawakami K
Mol Pharm; 2024 Apr; 21(4):1794-1803. PubMed ID: 38401048
[TBL] [Abstract][Full Text] [Related]
20. Molecular Dynamics and Physical Stability of Pharmaceutical Co-amorphous Systems: Correlation Between Structural Relaxation Times Measured by Kohlrausch-Williams-Watts With the Width of the Glass Transition Temperature (ΔT
Chieng N; Teo X; Cheah MH; Choo ML; Chung J; Hew TK; Keng PS
J Pharm Sci; 2019 Dec; 108(12):3848-3858. PubMed ID: 31542436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
